No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Expert Ratings For Blueprint Medicines
Needham Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $130
Blueprint Medicines Price Target Maintained With a $130.00/Share by Needham
Express News | Needham Reiterates Buy on Blueprint Medicines, Maintains $130 Price Target
Blueprint Medicines(BPMC.US) Officer Sells US$7.71 Million in Common Stock
Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing